CA9 and neuroblastoma: We have previously shown a poorer prognosis for CAIX-positive neuroblastoma patients in addition to the influence of hypoxia on progression and metastases in this disease, and were successfully able to inhibit neuroblastoma cell growth in vivo by applying the experimental CAIX inhibitors FC5-207A and FC8-325A [24,25].